Skip to main content
. 2017 Aug 24;8(44):77540–77551. doi: 10.18632/oncotarget.20560

Figure 5.

Figure 5

Distribution of clinicopathologic characteristics: tumor size, tumor grade, nodal status and pathologic response (A) disease-free (B) and overall survival (C) in patients from cohort #2 with and without TERT gene copy number gain. Patients with TERT gains had a significantly higher rate of incomplete pathologic responses and significantly shorter DFS and OS.